Diagnostic Pathology (Mar 2011)

Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia

  • Erdel Martin,
  • Wiesinger Kurt,
  • Rumpold Holger,
  • Tschurtschenthaler Gertraud,
  • Marschon Renate,
  • Boesmueller Hans,
  • Kranewitter Wolfgang,
  • Kralik Johanna M,
  • Petzer Andreas L,
  • Webersinke Gerald

DOI
https://doi.org/10.1186/1746-1596-6-19
Journal volume & issue
Vol. 6, no. 1
p. 19

Abstract

Read online

Abstract Background Characterization of novel fusion genes in acute leukemia is important for gaining information about leukemia genesis. We describe the characterization of a new ETV6 fusion gene in acute myeloid leukemia (AML) FAB M0 as a result of an uncommon translocation involving chromosomes 12 and 15. Methods The ETV6 locus at 12p13 was shown to be translocated and to constitute the 5' end of the fusion product by ETV6 break apart fluorescence in situ hybridisation (FISH). To identify a fusion partner 3' rapid amplification of cDNA-ends with polymerase chain reaction (RACE PCR) was performed followed by cloning and sequencing. Results The NTRK3 gene on chromosome 15 was found to constitute the 3' end of the fusion gene and the underlying ETV6-NTRK3 rearrangement was verified by reverse transcriptase PCR. No RNA of the reciprocal NTRK3-ETV6 fusion gene could be detected. Conclusion We have characterized a novel ETV6-NTRK3 fusion transcript which has not been previously described in AML FAB M0 by FISH and RACE PCR. ETV6-NTRK3 rearrangements have been described in secretory breast carcinoma and congenital fibrosarcoma.